Cyclobutane and methylcyclobutane derivatives as Janus kinase inhibitors

Details for Australian Patent Application No. 2011217961 (hide)

Owner Incyte Corporation

Inventors Li, Yun-Long; Rodgers, James D.

Agent Davies Collison Cave

Pub. Number AU-A-2011217961

PCT Pub. Number WO2011/103423

Priority 61/305,630 18.02.10 US

Filing date 18 February 2011

Wipo publication date 25 August 2011

International Classifications

C07D 487/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/519 - ortho- or peri-condensed with heterocyclic rings

A61P 17/00 Drugs for dermatological disorders

A61P 27/00 Drugs for disorders of the senses

A61P 29/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 Antineoplastic agents

A61P 37/00 Drugs for immunological or allergic disorders

Event Publications

6 September 2012 PCT application entered the National Phase

  PCT publication WO2011/103423 Priority application(s): WO2011/103423

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011217964-Monoclonal antibodies that inhibit the Wnt signaling pathway and methods of production and use thereof

2011217960-Apparatus and methods for providing information about one or more subterranean variables